apoptosis and cell death, which ultimately leads to the loss of brain functions. Currently, intra-arterial (IA) device-based therapy in multiple clinical trials has demonstrated efficacy for the treatment of acute ischemic stroke in patients. However, the short time window for surgery within 6 hours of stroke onset limits the successful rate in patients' treatment. 4, 5 For the majority of stroke patients, especially combined with complex syndromes, searching for an alternative drug administration or gene therapy becomes a serious and urgent issue.
Nerve growth factor (NGF) is the first identified and best characterized member of the neurotrophin family. Nerve growth factor (NGF) is an important regulator of neural survival, development, plasticity, known to play an important role in stimulating and modulating the differentiation as well as the maturation of developing and adult neurons in the central and peripheral nervous systems.
6-10
Exogenous administration of NGF has also been reported to prevent neuronal damage and contributes to the functional recovery after brain injury in animal brain injury models and human ischemia disease. [11] [12] [13] [14] However, as NGF is relatively impermeable to the bloodbrain barrier (BBB), it becomes difficult to accurately estimate the efficiency of reaching to the damaged brain lesion area by intramuscular injection. 15 The high dosages of NGF administration which are usually at microgram amounts are known to induce remarkable side effects such as aberrant sympathetic neurite sprouting, reduced weight gain and food intake. [16] [17] [18] Moreover, the invasive strategies of the NGF administration, for instance, intraventricular infusion, 14 could induce tissue damage, hemorrhage, hyperalgesia, and infections in clinical trials. 19, 20 In our previous study, we first cloned and identified the gene of β-NGF which encodes one of three NGF subunits and can exhibit all biological activities of the NGF.
21
Through microinjection of β-NGF carried by pseudolentivirus into the injured hippocampus after traumatic brain injury (TBI), β-NGF can last as long as 3 weeks in the brain and further rescued the impaired cognitive function of rats after TBI. 21 It suggests a potential application for pseudolentivirus-delivered NGF gene therapy in neuronal diseases.
To directly investigate a potential therapeutic NGF gene treatment in ischemic stroke disease, we used an established ischemic stroke model tMCAO in rats 22, 23 and estimated the effects on neuronal functional recovery in infarction core by pseudolentivirusdelivered β-NGF gene into the ischemic brain. We found that microinjection of β-NGF in striatum not only reduced the number of cell apoptosis by TUNEL labeling in both ischemic core and penumbra, but neurogenesis was also greatly increased in medialventral striatum characterized by cell proliferating marker Ki67.
Furthermore, the results of the Morris water maze behavior test supported that β-NGF overexpression in ischemic rat brain rescued the cognitive impairment which was largely mediated by upregulation of growth-associated protein 43 (GAP-43). Growth-associated protein 43 (GAP-43) is a nervous tissue-specific cytoplasmic protein and plays a key role in neurite formation and synaptic plasticity.
24,25
Hence, multiple brain functional evaluations illustrate de novo NGF gene therapy in ischemic disease. Ltd., UK), and rats with <20% reduction in cerebral blood flow at the core regions of the MCA territory were excluded from the study.
| MATERIALS AND METHODS

| Animals
After reperfusion for 24 hours, animals were sacrificed, and infarct volume in the brain was determined by TTC staining.
| Construction of pseudo lentivirus-carrying β-NGF fusion gene
The pseudo lentivirus-carrying β-NGF gene, fused with green fluorescent protein gene (Lv-NGF-GFP), was constructed as mentioned in our previous work. 21 In brief, the β-NGF gene was cloned into the modified lentiviral vector of the pLVX-IRES-ZsGreen1 (Clontech, Mountain View, CA, USA), which was cotransfected into the 293T cells with the packaging plasmid mixes (Clontech, Mountain View, CA, USA). The pseudo lentiviruswith GFP in the absence of β-NGF (Lv-GFP) was used as sham control.
| Lv-NGF-GFP/Lv-GFP microinjection in ischemic rat brain
Experimental ischemic rats were divided into 2 groups: Lv-NGF-GFP transfected tMCAO group and Lv-GFP transfected tMCAO group. In short, 5 μL (~1 × 10 8 TU/mL) of the lentivirus-carrying NGF-GFP or GFP was injected into the striatum of the ipsilateral hemisphere of the rat brain after the rat underwent ischemic surgery. For striatum injection site, coordinates were 1.8 mm anterior to bregma, 3 mm from the midline, and 5 mm deep from the dura. After 2-3 weeks of virus transfection, the animals were sacrificed and utilized for immunohistochemistry and Western blotting experiments.
| Immunohistochemistry and Western blotting
Twenty-four hours after lentivirus-transfected rats underwent ischemic surgery, they were perfused with 4% paraformaldehyde 
| Morris water maze assessment
The evaluation of the cognitive function in the rat was performed with the Morris water maze from the 14 days until the 20 days, after the lentivirus injection and brain ischemia as described in our previous study. 21 Briefly, the rats were tested in a black water maze. A black platform with a diameter of 12 and 2 cm lower than the water level was placed in the maze pool. The maze pool was divided into four equal quadrants. The rats were tested for swimming in each quadrant and rested for 4 minutes before the next round test was started. A 60-second time limit was set up for each rat to swim to the platform.
If the rat failed to find it, it was placed on the platform to rest for 10 seconds. The escape latency and the length of swimming path of the rat were collected for analysis.
| Statistical analysis
The data in this study were analyzed using one-way ANOVA (for three or more samples) followed by post hoc Tukey-Kramer multiple comparisons test. Statistical analysis was carried out using GraphPad
InStat (GraphPad Software). For all biochemistry and immunohistochemistry experiments, n values represent the number of rats. Results are presented as mean ± SEM, and statistical significance was set at *P < 0.05, **P < 0.01.
| RESULTS
| Establishment of tMCAO model of rat ischemia
First, we established a transient middle cerebral artery occlusion (tMCAO) ischemic model in rats. As shown in the cartoon and diagram of MCAO procedures ( Figure 1A ,B), the rat artery was occluded for 45 minutes, and the brain was reperfused for 24 hours. A series of brain sections were obtained and exhibited 2,3,5-triphenyltetrazolium chloride (TTC) staining to detect the extent of the tissue damage as shown in Figure 1C . From the TTC staining images in ipsilateral occlusion side, we could observe the hypoxia-induced ischemic injury that occurred in both cortex and striatum ( Figure 1C ), which were identified as the two major infarction core regions in the brain.
| Pseudo lentivirus-carrying β-NGF microinjection in striatum of ischemic rat brain
In our previously published study, we first cloned and identified the gene β-NGF, which encodes one of three NGF subunits and can exhibit all biological activities of NGF. 21 To investigate whether NGF has an impact on ischemia, the pseudo lentivirus-carrying β-NGF gene, fused with green fluorescent protein gene (Lv-NGF-GFP), was stereotaxically injected into the dorsal-lateral striatum (Figure 2A ,B).
Lv-NGF-GFP was successfully fused into striatal neurons after 
| β-NGF transfection reduces cell apoptosis and increases neurogenesis in infarct striatum after tMCAO in rats
It is well known that striatum is one of the infarction core brain regions in tMCAO and experiences cell damage and cell loss at the early onset of ischemia. Indeed, when we used TUNEL to label cell apoptosis which signals cell death progression, we found TUNELlabeled cells were largely restricted to the ischemic core and penumbra of dorsal striatum, and most TUNEL-labeled cells were colocalized with the neuronal nuclear marker NeuN ( Figure 3A,B) .
Due to the striatum being severely damaged after postischemia, it was hard to distinguish single TUNEL-labeled-positive cells in the striatal infarction core area. Thus, we calculated the apoptotic cell numbers by choosing the penumbra of the infarct region. As shown in the areas between the white-dotted lines among the three groups in Figure 3A -C, the TUNEL-labeled cells in Lv-NGF-GFP group were dramatically reduced compared with those in Lv-GFP group and sham group, respectively. The total TUNEL-positive cell numbers in the penumbra regions were as follows: Lv-NGF-GFP: 11 ± 0.58/mm 2 , n = 3 rats; Lv-GFP: 26.67 ± 1.33/mm 2 , n = 3 rats; tMCAO sham: 25.67 ± 1.76/mm 2 , n = 3 rats ( Figure 3D ). The statistical P values for ANOVA followed by Tukey-Kramer multiple comparisons test were as follows: P < 0.01, Lv-NGF-GFP vs Lv-GFP; P < 0.01, Lv-NGF-GFP vs tMCAO sham group; P > 0.05, Lv-GFP vs tMCAO sham group. Therefore, this observation indicated that NGF overexpression contributed to the improvement of cell survival in ischemia.
Nerve growth factor (NGF) microinjections in the brain reduced cell apoptosis in tMCAO, and interestingly, we further found a dramatic increase of neurogenesis in the medial-ventral striatum which was slightly away from the ischemic infarct core and penumbra regions ( Figure 4A-C) . Labeling with the cell proliferation marker Ki67, we counted the Ki67-positive cell numbers in Lv-NGF-GFP, Lv-GFP, and tMCAO sham group. The total proliferating cell numbers in these three groups were as follows: Lv-NGF-GFP: 35.33 ± 2.85/ mm 2 , n = 3 rats; Lv-GFP: 18.33 ± 1.67/mm 2 , n = 3 rats; tMCAO sham: 17.00 ± 0.58/mm 2 , n = 3 rats ( Figure 4D ). The statistical P values for ANOVA followed by Tukey-Kramer multiple comparisons test were as follows: P < 0.01, Lv-NGF-GFP vs Lv-GFP; P < 0.01, Lv-NGF-GFP vs tMCAO sham group; P > 0.05, Lv-GFP vs tMCAO sham group.
F I G U R E 1 Establishment of transient middle cerebral artery occlusion (tMCAO) model of rat ischemia. A-B,
The cartoon (A) and experimental procedure diagram (B) show a tMCAO model. In brief, a 6-to 8-wk-old male SD rat was anaesthetized, and a suture of 0.26 mm in diameter with a 0.36-mm-diameter tip was inserted into the internal carotid artery (ICA) through a cut of the common carotid artery (CCA) to occlude the middle cerebral artery (MCA). Reperfusion was allowed after 45 min by monofilament removal. C, triphenyltetrazolium chloride (TTC) staining images in ipsilateral occlusion side, the hypoxia-induced ischemic injury mostly occurred in both cerebral cortex and striatum in serial sections of tMCAO rat brain | 513 CAO et Al.
| β-NGF upregulation of GAP-43 promotes cognitive functional recovery
It is known that NGF plays a critical role in maintaining functional connections in adult brain neurons. [8] [9] [10] [11] [12] [13] 21 In a developing brain, low synthesis of NGF can negatively affect neurogenesis and neuroplasticity. 7, 28 To further assess the mechanism of neuroprotection by NGF after postischemia in rat, we investigated a potential intracellular signaling pathway, that is, growth-associated protein 43 (GAP-43), which mediates neuronal apoptosis and neurogenesis. 24, 25, 29, 30 As shown in Figure 5A , we found that the basal GAP-43 protein levels were very low in both tMCAO sham group and Lv-GFP transfected tMCAO group. However, a 2.1-fold and 2.5-fold increase of GAP-43 protein levels occurred in Lv-NGF-GFP transfected tMCAO group when compared with that in tMCAO sham control and Lv-GFP transfection group. The statistical P values were < 0.01 for Lv-NGF-GFP group compared with either Lv-GFP or tMCAO sham group.
During neuronal development or regeneration from brain injury, the expression of GAP-43 can fluctuate from very low levels in resting neurons to high levels in cells undergoing axonogenesis or synaptic plasticity. 24, 31 Therefore, the significantly elevated expression of GAP-43 mediated by NGF in our study prompted us to further estimate the cognitive functional recovery in postischemic rats. Morris water maze (MWM) task has often been used in the validation of neurocognitive disorders and the evaluation of possible neurocognitive treatments in rodent models. 32 The lesions in distinct brain regions such as hippocampus, striatum, cerebral cortex, and cerebellum are usually linked to impaired MWM performance. Therefore, we next investigated whether NGF overexpression could improve or rescue impaired cognitive functions after tMCAO in rats. We measured the standard performance during the acquisition phase of MWM task, including of escape latency and the total length of the swimming path. To our surprise, the escape latencies in Lv-NGF-GFP transfected tMCAO rats recovered to almost the normal range after 16 days for NGF microinjections when compared with wild-type rats ( Figure 5B ). On the contrast, Lv-GFP transfected tMCAO rats still showed distinct impairments in escape latency compared with wild-type rats (P < 0.05 for each day point). The Lv-NGF-GFP group also showed significant improvement of cognitive functions after day 16 compared with Lv-GFP group except at the examined day 18 ( Figure 5B) . A similar phenomenon was observed in the length of the swimming path of MWM task. As shown in Figure 5C , there was no significant difference in the total swimming distances between Lv-NGF-GFP tMCAO group and wild-type control group at each time point, which indicated NGF overexpression greatly improved an impaired working memory in ischemic rats. Moreover, Lv-GFP transfected tMCAO group did not show any improvement when compared with NGF-transfected tMCAO group since day 15 ( Figure 5C ). Taken together, this data suggested that NGF-induced upregulation of GAP-43 promoted neuronal axonogenesis and synaptic remodeling and eventually contributed to the cognitive functional recovery in ischemic rat model.
| DISCUSSION
Since the gene delivery method into the brain was first reported in 1998, over 100-fold range. 24, 31 High levels of GAP-43 protein expression in injured brain related to repair processes lend support to a morphological basis for long-term memory and synaptic plasticity. 24 Our current results showed that lentiviral delivery of NGF induced as high as 2-fold increase of GAP-43 proteins in ischemic infarction core, which indicated that an initial brain functional recovery occurred. Indeed, application of cognitive functional tests such as the Morris water maze further proved a rescue of learning and memory impairment in NGFtransfected tMCAO rats. the striatal ischemic penumbra of tMCAO sham group, Lv-GFP tMCAO group and Lv-NGF-GFP group. Values are represented as mean ± SEM n = 3 rats per group. **P < 0.01 Lv-NGF-GFP vs Sham or Lv-GFP group using ANOVA Turkey-Kramer multiple comparisons test
As a neurotrophin family member, NGF expresses broadly in both central nervous system (CNS) and peripheral nervous system (PNS). 6, 7 Previously published studies have shown that NGF plays an important role for neuronal survival, maturation, functional repair, and synaptic plasticity. [6] [7] [8] [9] [10] 21 In our present study, we provided more evidence that NGF promoted cell survival by reducing cell apoptosis and increasing cell proliferation in tMCAO rat brain. The escape latencies of Morris water maze performance are analyzed during the examined days after lentivirus transfection in both tMCAO and wild-type control rats. As shown in the graph, Lv-GFP transfected tMCAO group shows apparent impaired working learning memory compared with wild-type control group (P < 0.05, ANOVA post hoc test, n equals 6 for Lv-GFP group and 8 for wild-type control group). In contrast, Lv-NGF-GFP group shows improved functional recovery compared with that of Lv-GFP group starting at Day 16 after lentivirus transfections in tMCAO (*P < 0.05, Lv-NGF-GFP group vs Lv-GFP group at Day 16, 17, 19, 20) . Lv-NGF-GFP group shows no significant difference from wild-type control group after daily examination from day 16 ( ## P < 0.01, Lv-NGF-GFP group vs wild-type control at Day 15). C, The lengths of swimming path of Morris water maze performance were analyzed during the examined days after lentivirus transfection in tMCAO rats and wild-type control rats. As shown in the graph, Lv-GFP tMCAO group shows significantly impaired working learning memory compared with that in wild-type control (P < 0.05, ANOVA post hoc test, n equals 6 for Lv-GFP tMCAO group and 8 for wild-type control group). In contrast, Lv-NGF-GFP tMCAO group shows significant functional improvement compared with that in Lv-GFP tMCAO group starting at Day 15 after lentivirus transfection (*P < 0.05, Lv-NGF-GFP group vs Lv-GFP group at Day 15, 19, 20; **P < 0.01, Lv-NGF-GFP group vs Lv-GFP group at Day 16, 17, 18 . ANOVA post hoc test, n equals 5 for Lv-NGF-GFP group and 6 for Lv-GFP group)
